These outcomes, together with a previous report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two support the concept of targeting ACKR3 as a novel approach to modulate the opioid program, which could open new therapeutic avenues for opioid-similar Issues. (3) Apart from when the client https://johnv057gxh6.webbuzzfeed.com/profile